Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Healthcare Diagnostics & Research Medical Instruments & Supplies

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

TSX:EDT - Post by User

Spectral Medical Inc

<< Previous

Bullboard Posts

Next >>

(352)
•••

Post by hmmmmmmmmon Oct 07, 2025 6:11pm

155 Views

Post# 36741834

TIGRIS Unlocked: Evidence to Impact

Vantive's webinar singing the praises of PMX is next Tuesday at 12Pm (PDT)

Let's see what new eyes it brings...

Free to register:

https://learn.sepsis.org/products/vantive-sponsored-webinar-tigris-unlocked-evidence-to-impact

<< Previous

Bullboard Posts

Next >>

Aggressive drilling plans target gold and silver hotspots in Nevada